Aurobindo Pharma plans bio-equivalence centre at HyderabadIllustrative image – not actual.

Aurobindo Pharma is planning to set up a bio-equivalence centre in Hyderabad at a cost of Rs.10 crore. Bio-equivalence is usually done to ascertain the levels of similarity of generic products with existing products in the same segment.

 

 

← All latest storiesBack to top →